Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 28 January 1983:
Vol. 219. no. 4583, pp. 393 - 395
DOI: 10.1126/science.6184780
Prev | Table of Contents | Next

Articles

Science, Vol 219, Issue 4583, 393-395
Copyright © 1983 by American Association for the Advancement of Science

articles

A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man

GL Carlson, BU Li, P Bass, and WA Olsen

A commercial alpha-amylase inhibitor with potent inhibitory activity in vitro was used in a randomized double-blind, cross-over clinical trial in six nonobese, healthy adult males. In these subjects, this inhibitor had no effect on the response of blood glucose, insulin, or breath hydrogen to a standardized starch meal. It is concluded that this formulation has no effect on starch digestion in humans.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Bean alpha -amylase inhibitor 1 in transgenic peas (Pisum sativum) provides complete protection from pea weevil (Bruchus pisorum) under field conditions.
R. L. Morton, H. E. Schroeder, K. S. Bateman, M. J. Chrispeels, E. Armstrong, and T. J. V. Higgins (2000)
PNAS 97, 3820-3825
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)